Monday, September 1, 2025
HomeReportsPS Report: Nurexone...

PS Report: Nurexone Biologic-July 2024

From acute injury to functional recovery

Get notified whenever we post something new!

Continue reading

NexGen Energy’s Momentum Builds: Key Advances in Uranium Exploration and Sales Amid Global Energy Shift

In the rapidly evolving landscape of clean energy, NexGen Energy Ltd. continues to position itself as a pivotal player in the uranium sector. As the world grapples with the dual challenges of energy security and decarbonization, the Canadian company's...

Oregen’s Strategic Moves in Namibia’s Oil Boom

Namibia’s offshore Orange Basin has rapidly emerged as one of the world’s most promising oil exploration frontiers, driven by its substantial hydrocarbon potential and geological similarities to prolific regions like Guyana and Brazil’s Santos Basin. Since 2022, the basin...

Fueling Innovation: Canadian Healthcare Small-Caps Secure Key 2025 Financings

In 2025, a wave of Canadian healthcare companies have successfully raised fresh capital through private placements exceeding C$2.5 million, a sign of robust investor appetite for biotech and medtech innovation. These small-cap firms—from biotech therapeutics to medical technology developers secured...

Enjoy exclusive access to all of our content

Get an online subscription and you can unlock any article you come across.